PTSM: Pharmaceutical Technology Sourcing and Management, Dec 7, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Dec 7, 2011
Global Feature
Patent Reform and the Pharmaceutical Industry: From First-To-File To Post-Grant Review And Beyond
By Courtenay C. Brinckerhoff
The author discusses the major changes in US patent laws as a result of the recently signed patent-reform law and the implications for pharmaceutical companies.
APIs
Technical Perspective: Antibody Drug Conjugates
By Patricia Van Arnum
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Outsourcing
Biosimilars' Technology Needs
By Eric Langer
Biosimilar manufacturers need better expression systems and analytical tools to compete.
CSR and Sustainability Forum
Pharmaceutical Companies Target Green Manufacturing
A roundup of pharmaceutical companies' sustainability objectives and key projects.
World Health Organization Issues Progress Report on Combating HIV/AIDS
By Patricia Van Arnum
International efforts, including improving access to medicines, have contributed to stemming the rise of HIV/AIDS in the developing world.
CSR and Sustainability in the News
By Patricia Van Arnum
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here